|
|
|
| 
|
|
|
My Recent Searches
|
|
|
|
|
|
|
|
|
Kiora Pharmaceuticals (KPRX) |
|
|
$0.19 0.00 (0.00%) as of 4:30 Fri 2/14
|
|
Download |
|
|
| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
12,653,000 |
| Market
Cap: |
2.37(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$0.187 - $0.187 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Kiora Pharmaceuticals is a clinical-stage pharmaceutical company focused on developing products for treating disorders of the eye. Co.'s key product in clinical development is the EyeGate Ocular Bandage Gel, a topically applied eye drop formulation of modified hyaluronic acid (HA). HA is a naturally occurring polymer that is used in various physiological processes, including wound healing, hydration, tissue homeostasis, and joint lubrication. Co. modifies the HA through chemical cross-linking, which allows it to adhere to the ocular surface providing protection and lubrication for the treatment of corneal wounds, defects, and epitheliopathies.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-02-15 |
2023-11-14 |
2023-05-16 |
2022-05-16 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Daniels Eric Joseph |
Chief Development Officer |
• – – |
2023-09-29 |
4 |
A |
$0.00 |
$0 |
D/D |
62,500 |
88,338 |
|
- |
|
| Strem Brian M. |
President and CEO |
• • – |
2023-09-29 |
4 |
A |
$0.00 |
$0 |
D/D |
75,000 |
103,783 |
|
- |
|
| Tosca Melissa |
EVP Finance |
• – – |
2023-09-29 |
4 |
A |
$0.00 |
$0 |
D/D |
30,000 |
34,900 |
|
- |
|
| Daniels Eric Joseph |
Chief Development Officer |
• – – |
2023-03-03 |
4 |
A |
$0.00 |
$0 |
D/D |
15,600 |
25,838 |
|
- |
|
| Strem Brian M. |
President and CEO |
• • – |
2023-03-03 |
4 |
A |
$3.83 |
$59,748 |
D/D |
15,600 |
28,783 |
|
- |
|
| Tosca Melissa |
EVP Finance |
• – – |
2023-03-03 |
4 |
A |
$0.00 |
$0 |
D/D |
2,400 |
7,400 |
|
- |
|
| Daniels Eric Joseph |
Chief Development Officer |
• – – |
2022-10-21 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
10,238 |
|
- |
|
| Strem Brian M. |
President and CEO |
• • – |
2022-10-21 |
4 |
A |
$0.00 |
$0 |
D/D |
12,500 |
13,183 |
|
- |
|
| Tosca Melissa |
EVP of Finance |
• – – |
2022-10-21 |
4 |
A |
$0.00 |
$0 |
D/D |
2,500 |
2,500 |
|
- |
|
| Romano Sarah |
Chief Financial Officer |
• – – |
2022-02-10 |
4 |
D |
$0.69 |
$75 |
D/D |
(108) |
22,746 |
|
- |
|
| Romano Sarah |
Chief Financial Officer |
• – – |
2022-01-05 |
4 |
D |
$1.08 |
$123 |
D/D |
(114) |
22,854 |
|
- |
|
| From Stephen |
Executive Chairman |
• • – |
2022-01-05 |
4 |
D |
$1.08 |
$352 |
D/D |
(326) |
67,693 |
|
- |
|
| From Stephen |
Executive Chairman |
• • – |
2021-12-07 |
4 |
D |
$1.30 |
$355 |
D/D |
(273) |
68,019 |
|
- |
|
| Romano Sarah |
Chief Financial Officer |
• – – |
2021-12-07 |
4 |
D |
$1.30 |
$118 |
D/D |
(91) |
22,968 |
|
- |
|
| Mann Brenda |
VP of Research & Development |
• – – |
2021-11-02 |
4 |
D |
$1.98 |
$123 |
D/D |
(62) |
15,136 |
|
- |
|
| Romano Sarah |
Chief Financial Officer |
• – – |
2021-11-02 |
4 |
D |
$1.98 |
$164 |
D/D |
(83) |
23,059 |
|
- |
|
| From Stephen |
Executive Chairman |
• • – |
2021-11-02 |
4 |
D |
$1.98 |
$495 |
D/D |
(250) |
68,292 |
|
- |
|
| From Stephen |
Executive Chairman |
• • – |
2021-10-04 |
4 |
D |
$2.01 |
$500 |
D/D |
(249) |
68,542 |
|
- |
|
| Mann Brenda |
VP of Research & Development |
• – – |
2021-10-04 |
4 |
D |
$2.01 |
$125 |
D/D |
(62) |
15,198 |
|
- |
|
| Romano Sarah |
Chief Financial Officer |
• – – |
2021-10-04 |
4 |
D |
$2.01 |
$167 |
D/D |
(83) |
23,142 |
|
- |
|
| Mann Brenda |
VP of Research & Development |
• – – |
2021-09-02 |
4 |
D |
$1.81 |
$110 |
D/D |
(61) |
15,260 |
|
- |
|
| From Stephen |
Executive Chairman |
• • – |
2021-09-02 |
4 |
D |
$1.81 |
$458 |
D/D |
(253) |
68,791 |
|
- |
|
| Romano Sarah |
Chief Financial Officer |
• – – |
2021-09-02 |
4 |
D |
$1.81 |
$152 |
D/D |
(84) |
23,225 |
|
- |
|
| From Stephen |
Executive Chairman |
• • – |
2021-08-03 |
4 |
D |
$2.40 |
$626 |
D/D |
(261) |
69,044 |
|
- |
|
| Romano Sarah |
Chief Financial Officer |
• – – |
2021-08-03 |
4 |
D |
$2.40 |
$209 |
D/D |
(87) |
23,309 |
|
- |
|
289 Records found
|
|
Page 1 of 12 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
